New Pyridinone Alkaloid and Polyketide from the -Colonizing Fungus .
1/5 보강
One new pyridinone alkaloid pseudogymnone A () and one new tricyclic polyketide penijanthinone C (), together with six known compounds, harzianic acid (), 3-methyl-2-(2-nonenyl)-4(1)-quinolinone (), e
APA
Lin J, Guo Y, et al. (2026). New Pyridinone Alkaloid and Polyketide from the -Colonizing Fungus .. Biomolecules, 16(2). https://doi.org/10.3390/biom16020187
MLA
Lin J, et al.. "New Pyridinone Alkaloid and Polyketide from the -Colonizing Fungus .." Biomolecules, vol. 16, no. 2, 2026.
PMID
41750258 ↗
Abstract 한글 요약
One new pyridinone alkaloid pseudogymnone A () and one new tricyclic polyketide penijanthinone C (), together with six known compounds, harzianic acid (), 3-methyl-2-(2-nonenyl)-4(1)-quinolinone (), emodic acid (), alaternin (), violaceol-I (), and violaceol-II (), were obtained from the -colonizing fungus . The structures and absolute configurations of the isolated compounds were elucidated through a combination of NMR and MS spectroscopic analyses, ECD calculations, and X-ray crystallography. Compound exhibited obvious cytotoxicity against A549 (IC = 4.2 µM) and MGC (IC = 3.8 µM) cell lines. Integrated network pharmacology and molecular docking analyses indicated that compound exerts potential anti-gastric-cancer effects by modulating multiple cancer-related signaling pathways, with EGFR identified as a potential target of compound .
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Modified technique of chin augmentation with MEDPOR for Asian patients.
- Current status and prospects of methylthioadenosine phosphorylase/protein arginine methyltransferase 5 target therapy.
- Feasibility and preliminary efficacy of an art-making program to manage fear of cancer recurrence (AM-I-FCR) in lung cancer patients: a randomized controlled pilot study.
- Comparative safety analysis of enfortumab vedotin and pembrolizumab: monotherapy vs. combination therapy insights from FDA adverse event reporting system data.
- Efficacy and safety of Osimertinib and other third-generation EGFR TKIs in advanced NSCLC: a systematic review and meta-analysis.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.
- Early local immune activation following intra-operative radiotherapy in human breast tissue.